Toward a Clearer Framework for Machine Learning–Powered Risk Assessment: Insights From the SARCO X Study

We sincerely thank the authors for their careful evaluation and their detailed comments on our recent article entitled “Screening/diagnosing sarcopenia with machine learning–powered risk assessment: The SARCO X study."1 We are grateful for the opportunity to further clarify and elaborate on the issues raised.